Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)

计划入组 1,050 人 · 首次发布于 2021 年 3 月 3 日

Alive & Thrive Evaluation in Burkina Faso

计划入组 4,541 人 · 首次发布于 2015 年 5 月 6 日

Chemoprevention Efficacy Study in Burkina Faso

计划入组 800 人 · 首次发布于 2022 年 7 月 28 日

Furvina

C₆H₃Br₂NO₃

hcc49scFv-FasL

IASO-782

Mako Gold Ltd

IASO Pharma, Inc.

United States

FUSO PHARMACEUTICAL INDUSTRIES, LTD.

Japan

RH5.1/Matrix-M Vaccine Shows Promising Efficacy Against Malaria in African Children

Safety and Efficacy of the Blood-Stage Malaria Vaccine RH5

Lamivudine Prophylaxis Shows Promise in Preventing HIV Acquisition in Infants of Mothers with High Viral Load